BOUL Share Price Performance
SEK 0
-7.00 (-100.00%)
Price SEK 0
Share Pricen/a
Boule Diagnostics AB (publ) (STO:BOUL) Shares Fly 31% But Investors Aren't Buying For Growth
Nov 02
Boule Diagnostics AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
BOUL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Boule Diagnostics AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 11, 2026
- -2.09
- 43.45%
- -15.80%
- 119.3%
About BOUL
- Founded
- 1956
- Employees
- 200
- CEO
- WebsiteView website
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
